​

Laboratory Corporation of America (LH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LH Stock Forecast

Laboratory Corporation of America stock forecast is as follows: an average price target of $258.20 (represents a 4.87% upside from LH’s last price of $246.22) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

LH Price Target

The average price target for Laboratory Corporation of America (LH) is $258.20 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $277.00 to $240.00. This represents a potential 4.87% upside from LH's last price of $246.22.

LH Analyst Ratings

Buy

According to 11 Wall Street analysts, Laboratory Corporation of America's rating consensus is 'Buy'. The analyst rating breakdown for LH stock is 0 'Strong Buy' (0.00%), 7 'Buy' (63.64%), 4 'Hold' (36.36%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Laboratory Corporation of America Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Elizabeth AndersonEvercore ISI$240.00$224.726.80%-2.53%
Sep 23, 2024Brian TanquilutJefferies$265.00$222.2219.25%7.63%
Aug 05, 2024Michael RyskinBank of America Securities$260.00$236.0010.17%5.60%
Aug 02, 2024Eric ColdwellRobert W. Baird$277.00$235.6717.54%12.50%
Aug 02, 2024Stephanie DavisBarclays$249.00$235.675.66%1.13%
Mar 25, 2024David ToungArgus Research$250.00$212.5017.65%1.54%
Jan 06, 2023Morgan Stanley$303.00$241.4225.51%23.06%
Nov 23, 2022Credit Suisse$305.00$238.0028.15%23.87%
Jul 29, 2022Mizuho Securities$296.00$254.7216.21%20.22%
May 03, 2022Deutsche Bank$265.00$245.457.96%7.63%
May 02, 2022Credit Suisse$312.00$240.2829.85%26.72%
Apr 25, 2022Wells Fargo$315.00$266.1218.37%27.93%
Feb 11, 2022Derik de BruinBank of America Securities$370.00$276.2633.93%50.27%
Jan 28, 2022Pito ChickeringDeutsche Bank$294.00$270.088.86%19.41%
Jul 30, 2021David S MacdonaldTruist Financial$350.00$296.1518.18%42.15%
May 20, 2021Jasper HellwegArgus Research$295.00$269.619.42%19.81%

The latest Laboratory Corporation of America stock forecast, released on Sep 24, 2024 by Elizabeth Anderson from Evercore ISI, set a price target of $240.00, which represents a 6.80% increase from the stock price at the time of the forecast ($224.72), and a -2.53% decrease from LH last price ($246.22).

Laboratory Corporation of America Price Target by Period

1M3M12M
# Anlaysts--6
Avg Price Target--$256.83
Last Closing Price$246.22$246.22$246.22
Upside/Downside-100.00%-100.00%4.31%

In the current month, the average price target of Laboratory Corporation of America stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Laboratory Corporation of America's last price of $246.22. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Jan 07, 2025Evercore ISIOutperformUpgrade
Oct 30, 2024HSBCBuyUpgrade
Oct 01, 2024Piper SandlerNeutralInitialise
Sep 23, 2024JefferiesBuyBuyHold
Aug 05, 2024Bank of America SecuritiesBuyBuyHold
Aug 02, 2024BarclaysEqual-WeightEqual-WeightHold
Aug 02, 2024UBSBuyBuyHold
Jan 06, 2023Morgan StanleyOverweightOverweightHold
Dec 12, 2022CitigroupNeutralDowngrade
Nov 23, 2022Credit SuisseOutperformOutperformHold
Aug 01, 2022Credit SuisseOutperformOutperformHold
May 02, 2022Credit SuisseOutperformOutperformHold
Jan 28, 2022Deutsche BankHoldDowngrade

Laboratory Corporation of America's last stock rating was published by Evercore ISI on Jan 07, 2025. The company Upgrade its LH rating from "null" to "Outperform".

Laboratory Corporation of America Financial Forecast

Laboratory Corporation of America Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$3.03B$3.06B$3.03B$3.78B$3.67B$3.61B$3.70B$3.90B$4.06B$4.06B$3.84B$4.16B$4.49B$3.90B$2.77B$2.82B$2.95B$2.93B
Avg Forecast$3.63B$3.64B$3.63B$3.58B$3.47B$3.47B$3.46B$3.41B$3.31B$3.26B$3.19B$3.12B$3.02B$2.99B$3.77B$3.69B$3.74B$3.79B$3.75B$4.01B$3.92B$3.65B$3.61B$3.91B$4.04B$3.65B$2.48B$2.80B$2.93B$2.91B
High Forecast$3.69B$3.69B$3.68B$3.64B$3.53B$3.53B$3.52B$3.46B$3.32B$3.26B$3.19B$3.12B$3.03B$3.02B$3.83B$3.75B$3.79B$3.79B$3.75B$4.01B$3.92B$3.65B$3.61B$3.91B$4.04B$3.65B$2.48B$2.80B$2.93B$2.91B
Low Forecast$3.57B$3.57B$3.57B$3.52B$3.41B$3.41B$3.40B$3.37B$3.29B$3.26B$3.19B$3.12B$3.01B$2.93B$3.70B$3.63B$3.68B$3.79B$3.75B$4.01B$3.92B$3.65B$3.61B$3.91B$4.04B$3.65B$2.48B$2.80B$2.93B$2.91B
# Analysts6446437910934711595447551075159988
Surprise %------------1.01%1.02%0.81%1.02%0.98%0.95%0.99%0.97%1.04%1.11%1.06%1.06%1.11%1.07%1.12%1.01%1.01%1.01%

Laboratory Corporation of America's average Quarter revenue forecast for Mar 24 based on 4 analysts is $3.12B, with a low forecast of $3.12B, and a high forecast of $3.12B. LH's average Quarter revenue forecast represents a 2.80% increase compared to the company's last Quarter revenue of $3.03B (Dec 23).

Laboratory Corporation of America EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts6446437910934711595447551075159988
EBITDA------------$375.70M$436.70M$411.70M$503.00M$530.30M$636.00M$720.40M$856.50M$916.50M$996.00M$915.40M$1.25B$1.47B$1.15B$493.60M$-68.40M$512.90M$491.90M
Avg Forecast$670.59M$671.55M$669.81M$661.63M$641.38M$641.35M$639.65M$630.58M$611.17M$602.31M$588.38M$998.21M$557.46M$552.65M$695.87M$907.46M$859.49M$760.15M$753.28M$824.97M$786.38M$731.95M$724.94M$1.02B$810.07M$733.24M$497.98M$-53.67M$587.55M$583.77M
High Forecast$681.08M$682.06M$680.29M$671.98M$651.41M$651.38M$649.65M$639.80M$613.01M$602.48M$588.38M$1.20B$559.31M$557.81M$706.76M$1.09B$1.03B$760.15M$753.28M$989.96M$786.38M$731.95M$724.94M$1.23B$810.07M$733.24M$497.98M$-42.93M$587.55M$583.77M
Low Forecast$659.28M$660.22M$658.51M$650.47M$630.55M$630.52M$628.85M$623.20M$607.49M$602.14M$588.38M$798.57M$555.60M$540.81M$684.13M$725.97M$687.59M$760.15M$753.28M$659.97M$786.38M$731.95M$724.94M$819.38M$810.07M$733.24M$497.98M$-64.40M$587.55M$583.77M
Surprise %------------0.67%0.79%0.59%0.55%0.62%0.84%0.96%1.04%1.17%1.36%1.26%1.22%1.82%1.57%0.99%1.27%0.87%0.84%

4 analysts predict LH's average Quarter EBITDA for Mar 24 to be $998.21M, with a high of $1.20B and a low of $798.57M. This is 165.69% upper than Laboratory Corporation of America's previous annual EBITDA (Dec 23) of $375.70M.

Laboratory Corporation of America Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts6446437910934711595447551075159988
Net Income------------$-167.10M$183.30M$188.90M$212.90M$76.10M$352.80M$358.60M$491.60M$553.60M$587.30M$467.40M$769.60M$938.30M$703.40M$231.60M$-317.20M$227.10M$220.70M
Avg Forecast$357.81M$376.59M$393.76M$367.51M$338.32M$344.03M$346.44M$326.71M$286.30M$293.08M$318.69M$581.90M$274.90M$281.32M$323.73M$529.00M$518.60M$337.98M$340.27M$480.91M$432.05M$356.08M$403.58M$628.73M$587.30M$384.39M$72.81M$-248.88M$202.68M$206.10M
High Forecast$365.08M$384.24M$401.76M$374.98M$345.20M$351.03M$353.48M$340.12M$294.72M$296.10M$318.69M$698.29M$284.09M$290.64M$330.31M$634.81M$622.32M$337.98M$340.27M$577.10M$432.05M$356.08M$403.58M$754.48M$587.30M$384.39M$72.81M$-199.10M$202.68M$206.10M
Low Forecast$349.96M$368.32M$385.12M$359.44M$330.90M$336.49M$338.84M$309.12M$279.56M$290.07M$318.69M$465.52M$270.72M$263.53M$316.62M$423.20M$414.88M$337.98M$340.27M$384.73M$432.05M$356.08M$403.58M$502.98M$587.30M$384.39M$72.81M$-298.66M$202.68M$206.10M
Surprise %-------------0.61%0.65%0.58%0.40%0.15%1.04%1.05%1.02%1.28%1.65%1.16%1.22%1.60%1.83%3.18%1.27%1.12%1.07%

Laboratory Corporation of America's average Quarter net income forecast for Dec 23 is $274.90M, with a range of $270.72M to $284.09M. LH's average Quarter net income forecast represents a 49.97% increase compared to the company's last Quarter net income of $183.30M (Sep 23).

Laboratory Corporation of America SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts6446437910934711595447551075159988
SG&A------------$532.90M$525.50M$505.80M$553.60M$536.50M$510.00M$486.00M$464.10M$543.70M$519.90M$458.70M$429.80M$518.00M$419.50M$396.30M$395.50M$413.90M$401.50M
Avg Forecast$497.97M$498.68M$497.39M$491.32M$476.28M$476.25M$474.99M$468.26M$453.84M$447.27M$436.92M$549.35M$413.96M$410.39M$516.74M$499.41M$509.88M$519.35M$514.65M$454.01M$537.27M$500.08M$495.29M$351.13M$553.45M$500.97M$340.23M$310.32M$401.43M$398.84M
High Forecast$505.76M$506.48M$505.17M$499.00M$483.73M$483.70M$482.42M$475.10M$455.21M$447.39M$436.92M$659.22M$415.33M$414.22M$524.82M$599.29M$611.86M$519.35M$514.65M$544.81M$537.27M$500.08M$495.29M$421.35M$553.45M$500.97M$340.23M$372.38M$401.43M$398.84M
Low Forecast$489.57M$490.27M$488.99M$483.02M$468.24M$468.21M$466.98M$462.78M$451.11M$447.14M$436.92M$439.48M$412.58M$401.60M$508.02M$399.53M$407.90M$519.35M$514.65M$363.21M$537.27M$500.08M$495.29M$280.90M$553.45M$500.97M$340.23M$248.25M$401.43M$398.84M
Surprise %------------1.29%1.28%0.98%1.11%1.05%0.98%0.94%1.02%1.01%1.04%0.93%1.22%0.94%0.84%1.16%1.27%1.03%1.01%

Laboratory Corporation of America's average Quarter SG&A projection for Mar 24 is $549.35M, based on 4 Wall Street analysts, with a range of $439.48M to $659.22M. The forecast indicates a 3.09% rise compared to LH last annual SG&A of $532.90M (Dec 23).

Laboratory Corporation of America EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts6446437910934711595447551075159988
EPS------------$-1.95$2.12$2.14$2.41$0.86$3.91$3.89$5.27$5.81$6.10$4.80$7.88$9.62$7.22$2.38$-3.27$2.34$2.26
Avg Forecast$4.24$4.46$4.67$4.35$4.01$4.08$4.10$3.87$3.39$3.47$3.78$3.48$3.26$3.33$3.84$3.40$3.53$4.01$4.04$5.13$5.13$4.22$4.79$6.40$6.97$4.56$0.86$1.85$2.40$2.44
High Forecast$4.33$4.55$4.76$4.44$4.09$4.16$4.19$4.03$3.49$3.51$3.78$3.48$3.37$3.44$3.91$3.47$3.58$4.01$4.04$5.13$5.13$4.22$4.79$6.40$6.97$4.56$0.86$1.85$2.40$2.44
Low Forecast$4.15$4.36$4.56$4.26$3.92$3.99$4.01$3.66$3.31$3.44$3.78$3.48$3.21$3.12$3.75$3.32$3.46$4.01$4.04$5.13$5.13$4.22$4.79$6.40$6.97$4.56$0.86$1.85$2.40$2.44
Surprise %-------------0.60%0.64%0.56%0.71%0.24%0.98%0.96%1.03%1.13%1.44%1.00%1.23%1.38%1.58%2.76%-1.77%0.97%0.92%

According to 7 Wall Street analysts, Laboratory Corporation of America's projected average Quarter EPS for Dec 23 is $3.26, with a low estimate of $3.21 and a high estimate of $3.37. This represents a 53.63% increase compared to LH previous annual EPS of $2.12 (Sep 23).

Laboratory Corporation of America Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
UHSUniversal Health Services$187.18$274.0046.38%Hold
HOLXHologic$71.41$87.3322.29%Buy
DGXQuest Diagnostics$155.44$173.8311.83%Buy
LHLaboratory Corporation of America$246.22$258.204.87%Buy
HUMHumana$294.23$276.71-5.95%Hold
WATWaters$404.17$371.00-8.21%Buy

LH Forecast FAQ

Is Laboratory Corporation of America a good buy?

Yes, according to 11 Wall Street analysts, Laboratory Corporation of America (LH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 63.64% of LH's total ratings.

What is LH's price target?

Laboratory Corporation of America (LH) average price target is $258.2 with a range of $240 to $277, implying a 4.87% from its last price of $246.22. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Laboratory Corporation of America stock go up soon?

According to Wall Street analysts' prediction for LH stock, the company can go up by 4.87% (from the last price of $246.22 to the average price target of $258.2), up by 12.50% based on the highest stock price target, and down by -2.53% based on the lowest stock price target.

Can Laboratory Corporation of America stock reach $400?

LH's average twelve months analyst stock price target of $258.2 does not support the claim that Laboratory Corporation of America can reach $400 in the near future.

What are Laboratory Corporation of America's analysts' financial forecasts?

Laboratory Corporation of America's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $13.82B (high $14.03B, low $13.61B), average EBITDA is $2.55B (high $2.59B, low $2.51B), average net income is $1.36B (high $1.39B, low $1.32B), average SG&A $1.9B (high $1.92B, low $1.87B), and average EPS is $16.06 (high $16.47, low $15.58). LH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $14.47B (high $14.7B, low $14.23B), average EBITDA is $2.67B (high $2.72B, low $2.63B), average net income is $1.5B (high $1.53B, low $1.46B), average SG&A $1.99B (high $2.02B, low $1.95B), and average EPS is $17.72 (high $18.08, low $17.33).

Did the LH's actual financial results beat the analysts' financial forecasts?

Based on Laboratory Corporation of America's last annual report (Dec 2023), the company's revenue was $12.16B, which missed the average analysts forecast of $13.47B by -9.71%. Apple's EBITDA was $1.7B, missing the average prediction of $2.71B by -37.31%. The company's net income was $418M, missing the average estimation of $1.41B by -70.33%. Apple's SG&A was $2.02B, beating the average forecast of $1.84B by 9.83%. Lastly, the company's EPS was $4.77, missing the average prediction of $13.82 by -65.50%. In terms of the last quarterly report (Dec 2023), Laboratory Corporation of America's revenue was $3.03B, beating the average analysts' forecast of $3.02B by 0.51%. The company's EBITDA was $375.7M, missing the average prediction of $557.46M by -32.60%. Laboratory Corporation of America's net income was $-167M, missing the average estimation of $274.9M by -160.79%. The company's SG&A was $532.9M, beating the average forecast of $413.96M by 28.73%. Lastly, the company's EPS was $-1.95, missing the average prediction of $3.26 by -159.87%